Evidence map›Paper›PMID 35056112›Full record

ArticlePharmaceuticals (Basel, Switzerland)2022

Synthetic Derivatives against Wild-Type and Non-Wild-Type

Lais Cavalcanti Dos Santos Velasco de Souza, Lucas Martins Alcântara, Pãmella Antunes de Macêdo-Sales, Nathália Faria Reis, Débora Sena de Oliveira, Ricardo Luiz Dantas Machado, Reinaldo Barros Geraldo, André Luis Souza Dos Santos, Vítor Francisco Ferreira, Daniel Tadeu Gomes Gonzaga and 3 more

Open access · goldAbstract read
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 9 citations in OpenAlex.

  1. Toxicogenetic profiling of an antifungal lawsone silver salt: in silico and in vitro analysis in 2D and 3D mammalian models.Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Journal of fungi (Basel, Switzerland) · 2023
    Review
  6. Are γ-terpinene, 1,8-cineole, p-coumaric acid, and quercetin active against wild-type and non-wild-type Sporothrix brasiliensis to itraconazole?Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2023
    Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Lais Cavalcanti Dos Santos Velasco de SouzaCenter for Microorganisms' Investigation, Fluminense Federal University, Niterói 24020-150, Brazil.ORCID 0000-0003-0245-2687
Lucas Martins AlcântaraCenter for Microorganisms' Investigation, Fluminense Federal University, Niterói 24020-150, Brazil.
Pãmella Antunes de Macêdo-SalesCenter for Microorganisms' Investigation, Fluminense Federal University, Niterói 24020-150, Brazil.
Nathália Faria ReisCenter for Microorganisms' Investigation, Fluminense Federal University, Niterói 24020-150, Brazil.
Débora Sena de OliveiraCenter for Microorganisms' Investigation, Fluminense Federal University, Niterói 24020-150, Brazil.
Ricardo Luiz Dantas MachadoCenter for Microorganisms' Investigation, Fluminense Federal University, Niterói 24020-150, Brazil.ORCID 0000-0002-8955-3204
Reinaldo Barros GeraldoLaboratory of Antibiotics, Biochemistry and Molecular Modeling, Institute of Biology, Fluminense Federal University, Niterói 24210-201, Brazil.
André Luis Souza Dos SantosLaboratory of Advanced Studies of Emerging and Resistant Microorganisms, Federal University of Rio de Janeiro, Rio de Janeiro 21941-902, Brazil.ORCID 0000-0003-0821-8592
Vítor Francisco FerreiraDepartment of Pharmaceutical Technology, Faculty of Pharmacy, Graduate Program in Applied Health Sciences, Niterói 24241-000, Brazil.ORCID 0000-0002-2166-766X
Daniel Tadeu Gomes GonzagaPharmacy Unit, State University of the West Zone, Rio de Janeiro 23070-200, Brazil.
Fernando de Carvalho da SilvaDepartment of Organic Chemistry, Institute of Chemistry, Fluminense Federal University, Niterói 24020-150, Brazil.ORCID 0000-0002-2042-3778
Helena Carla CastroLaboratory of Antibiotics, Biochemistry and Molecular Modeling, Institute of Biology, Fluminense Federal University, Niterói 24210-201, Brazil.
Andréa Regina de Souza BaptistaCenter for Microorganisms' Investigation, Fluminense Federal University, Niterói 24020-150, Brazil.ORCID 0000-0002-0461-7521
Universidade Federal Fluminense · BRUniversidade Estadual da Zona Oeste · BRUniversidade Federal do Rio de Janeiro · BR

Funding

Coordenação de Aperfeicoamento de Pessoal de Nível Superior Financial Code 001Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro E-26/010.001882/2014Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro E-26/103.198/2011National Council for Scientific and Technological Development PQ- CNPQ 308097/2016-5
6 · The paper itself

Abstract

Recently, the well-known geographically wide distribution of sporotrichosis in Brazil, combined with the difficulties of effective domestic feline treatment, has emphasized the pressing need for new therapeutic alternatives. This work considers a range of synthetic derivatives as potential antifungals against

Indexed as

Felis catushydrazonesquinonessporotrichosiszoonoses

Identifiers

PMID35056112
PMCPMC8781075
OpenAlexW4206069157

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.